Trials / Unknown
UnknownNCT02607670
Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 111 (estimated)
- Sponsor
- Topokine Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the reduction of moderate to severe nasolabial folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAT4 Gel | |
| DRUG | Matching placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2015-11-18
- Last updated
- 2016-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02607670. Inclusion in this directory is not an endorsement.